首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
【24h】

Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma

机译:葡萄球菌肠毒素A(SEA)刺激皮肤T细胞淋巴瘤中的STAT3激活和IL-17表达

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Cutaneous T-cell lymphoma (CTCL) is characterized by proliferation of malignant T cells in a chronic inflammatory environment. With disease progression, bacteria colonize the compromised skin barrier and half of CTCL patients die of infection rather than from direct organ involvement by the malignancy. Clinical data indicate that bacteria play a direct role in disease progression, but little is known about the mechanisms involved. Here, we demonstrate that bacterial isolates containing staphylococcal enterotoxin A (SEA) from the affected skin of CTCL patients, as well as recombinant SEA, stimulate activation of signal transducer and activator of transcription 3 (STAT3) and upregulation of interleukin (IL)-17 in immortalized and primary patient-derived malignant and nonmalignant T cells. Importantly, SEA induces STAT3 activation and IL-17 expression in malignant T cells when cocultured with nonmalignant T cells, indicating an indirect mode of action. In accordance, malignant T cells expressing an SEA-nonresponsive T-cell receptor variable region beta chain are nonresponsive to SEA in monoculture but display strong STAT3 activation and IL-17 expression in cocultures with SEA-responsive nonmalignant T cells. The response is induced via IL-2 receptor common gamma chain cytokines and a Janus kinase 3 (JAK3)-dependent pathway in malignant T cells, and blocked by tofacitinib, a clinical-grade JAK3 inhibitor. In conclusion, we demonstrate that SEA induces cell cross talk-dependent activation of STAT3 and expression of IL-17 in malignant T cells, suggesting a mechanism whereby SEA-producing bacteria promote activation of an established oncogenic pathway previously implicated in carcinogenesis.
机译:皮肤T细胞淋巴瘤(CTCL)的特征在于在慢性炎症环境中恶性T细胞的增殖。随着疾病的进展,细菌会在受损的皮肤屏障上定居,一半的CTCL患者会死于感染,而不是由恶性肿瘤直接侵害器官。临床数据表明细菌在疾病进展中起直接作用,但对所涉及的机制知之甚少。在这里,我们证明了从患CTCL患者的皮肤中含有葡萄球菌肠毒素A(SEA)的细菌分离株,以及重组SEA,可刺激信号转导子和转录激活子3(STAT3)的激活以及白介素(IL)-17的上调在永生化和原发性患者来源的恶性和非恶性T细胞中重要的是,当与非恶性T细胞共培养时,SEA会在恶性T细胞中诱导STAT3激活和IL-17表达,这表明是间接作用方式。因此,表达SEA无反应性T细胞受体可变区β链的恶性T细胞在单培养中对SEA无反应,但在与SEA反应性非恶性T细胞共培养中显示出强大的STAT3激活和IL-17表达。该反应是通过IL-2受体常见的γ链细胞因子和Janus激酶3(JAK3)依赖性途径在恶性T细胞中诱导的,并被临床级JAK3抑制剂tofacitinib阻断。总之,我们证明SEA会诱导恶性T细胞中STAT3的细胞串扰依赖性激活和IL-17的表达,这表明产生SEA的细菌促进先前与致癌作用有关的已建立的致癌途径的激活的机制。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号